Article Details
Retrieved on: 2021-06-27 22:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Many humanized anti-NGF monoclonal antibodies (mAbs) have been tested in clinical trials as potential pain therapies (ie tanezumab, fulranumab, and ...
Article found on: www.dovepress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here